LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 72.24 | 21.74 | 10602 | 6162 | 1.7205 | 1.1378 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.21 | 21.74 | 1768 | 6235 | 0.2835 | 0.7139 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.21 | 21.74 | 10456 | 6235 | 1.6768 | 1.1307 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.21 | 21.74 | 10 | 6235 | 0.0016 | -0.0907 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.21 | 21.74 | 11129 | 6235 | 1.7848 | 1.1471 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.18 | 21.74 | 2097 | 6114 | 0.3430 | 0.7535 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.18 | 21.74 | 10936 | 6114 | 1.7886 | 1.1482 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.18 | 21.74 | 6 | 6114 | 0.0010 | -0.1464 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.18 | 21.74 | 11538 | 6114 | 1.8870 | 1.1624 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.15 | 21.74 | 2273 | 6167 | 0.3685 | 0.7694 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.15 | 21.74 | 11196 | 6167 | 1.8153 | 1.1518 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.15 | 21.74 | 13 | 6167 | 0.0021 | -0.0612 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.15 | 21.74 | 11867 | 6167 | 1.9241 | 1.1673 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.12 | 21.74 | 2255 | 6211 | 0.3630 | 0.7664 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.12 | 21.74 | 11446 | 6211 | 1.8426 | 1.1556 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.12 | 21.74 | 45 | 6211 | 0.0072 | 0.0933 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.12 | 21.74 | 12264 | 6211 | 1.9743 | 1.1739 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.09 | 21.74 | 2259 | 6201 | 0.3643 | 0.7671 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.09 | 21.74 | 11665 | 6201 | 1.8811 | 1.1611 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.09 | 21.74 | 25 | 6201 | 0.0040 | 0.0173 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.09 | 21.74 | 12497 | 6201 | 2.0152 | 1.1794 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 84.06 | 21.74 | 2275 | 6152 | 0.3698 | 0.7700 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 84.06 | 21.74 | 11924 | 6152 | 1.9382 | 1.1693 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 84.06 | 21.74 | 2 | 6152 | 0.0003 | -0.2539 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 84.06 | 21.74 | 12633 | 6152 | 2.0534 | 1.1847 | MN20160310_N01 | G18 |